Editas Medicine Inc (NASDAQ:EDIT)

North American company
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - EDIT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - EDIT

  • Market Cap$1.269bn
  • SymbolNASDAQ:EDIT
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS28106W1036

Company Profile

Editas Medicine Inc is a US-based genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company operates its business in a single segment of Developing and commercializing genome editing technology.Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.

Latest EDIT news

Currently there for this company. Visit our news hub for other news .